Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacokinetics and Pharmacodynamics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women: A Cross-Compartmental Study With Directly Observed Dosing
Jessica Justman, Gonasagrie Nair, Craig W. Hendrix, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2018) Vol. 78, Iss. 2, pp. 175-182
Open Access | Times Cited: 10

Showing 10 citing articles:

Topical Microbicides in HIV Prevention: State of the Promise
Jared M. Baeten, Craig W. Hendrix, Sharon L. Hillier
Annual Review of Medicine (2019) Vol. 71, Iss. 1, pp. 361-377
Open Access | Times Cited: 42
HIV Antiretroviral Pre‐Exposure Prophylaxis: Development Challenges and Pipeline Promise
Craig W. Hendrix
Clinical Pharmacology & Therapeutics (2018) Vol. 104, Iss. 6, pp. 1082-1097
Open Access | Times Cited: 21
Topical delivery of long-acting antiretrovirals to prevent HIV acquisition
Thesla Palanee‐Phillips, Jared M. Baeten
Current Opinion in HIV and AIDS (2019) Vol. 15, Iss. 1, pp. 42-48
Open Access | Times Cited: 15
Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc
Kathleen L. Vincent, John A. Moss, Mark A. Marzinke, et al.
PLoS ONE (2018) Vol. 13, Iss. 8, pp. e0201952-e0201952
Open Access | Times Cited: 14
Brief Report: Anal Intercourse, HIV-1 Risk, and Efficacy in a Trial of a Dapivirine Vaginal Ring for HIV-1 Prevention
Kathryn Peebles, Ariane van der Straten, Thesla Palanee‐Phillips, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2019) Vol. 83, Iss. 3, pp. 197-201
Open Access | Times Cited: 10
Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis: A First-In-Human Study
Amer Al‐khouja, Eugenie Shieh, Edward J. Fuchs, et al.
AIDS Research and Human Retroviruses (2020) Vol. 37, Iss. 6, pp. 444-452
Open Access | Times Cited: 8
Evaluation of the Safety, Acceptability, and Pharmacokinetic Profile of a Gel Formulation of OB-002 in Healthy Volunteers
Ian McGowan, Niko Tzakis, Beata Kosak, et al.
AIDS Research and Human Retroviruses (2021) Vol. 37, Iss. 6, pp. 453-460
Closed Access | Times Cited: 7
A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety, and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026)
Ross Cranston, Elizabeth R. Brown, José A. Bauermeister, et al.
AIDS Research and Human Retroviruses (2021) Vol. 38, Iss. 4, pp. 257-268
Open Access | Times Cited: 7
Phase I Dose Volume Escalation of Rectally Administered PC-1005 to Assess Safety, Pharmacokinetics, and Antiviral Pharmacodynamics as a Multipurpose Prevention Technology (MTN-037)
Ken Ho, Craig Hoesley, Peter L. Anderson, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2024) Vol. 97, Iss. 4, pp. 379-386
Closed Access
Brief Report: Dapivirine Ring HIV-1 Prevention Effectiveness for Women Engaged in Vaginal and Anal Intercourse: Insights From Mathematical Modeling
Kathryn Peebles, Elizabeth R. Brown, Craig W. Hendrix, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2022) Vol. 92, Iss. 2, pp. 122-126
Open Access | Times Cited: 1
Page 1

Scroll to top